Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly patients with colorectal cancer: A population-based propensity score–matched cohort study

The commonly used vaccine for adults with a high risk of pneumonia is 23-valent pneumococcal polysaccharide vaccine (PPSV23). However, its effectiveness in patients with colorectal cancer has not been investigated. This study aimed to investigate the effectiveness of PPSV23 in reducing the risk of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiou, Wen-Yen, Hung, Shih-Kai, Lin, Hon-Yi, Chen, Liang-Cheng, Hsu, Feng-Chun, Tsai, Shiang-Jiun, Yu, Ben-Hui, Lee, Moon-Sing, Li, Chung-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922596/
https://www.ncbi.nlm.nih.gov/pubmed/31852152
http://dx.doi.org/10.1097/MD.0000000000018380